Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCitigroup Inc Regulatory News (13PH)

  • There is currently no data for 13PH

Article 8

30 Apr 2020 12:25

RNS Number : 5171L
Citigroup Inc
30 April 2020
 

29 April 2020

NOTICE

pursuant to the Final Terms dated 20 February 2020 as amended and restated by the Amended and Restated Final Terms dated 11 March 2020 and by the Amended and Restated Final Terms dated 24 April 2020 (the "Final Terms")

relating to

Citigroup Inc.

Legal Entity Identifier (LEI): 6SHGI4ZSSLCXXQSBB395

Issue of Up to USD 30,000,000 Citigroup Inc. USD 5y Callable Step Up

(referred to by the Distributor as "Citigroup Step Up Callable USD Aprile 2025")

Under the Citi U.S.$60,000,000,000 Global Medium Term Note Programme

 

(Series Number: EMTN7711, ISIN: XS1273437480)

 

The Issuer hereby provides notice in accordance with the Final Terms that:

(a) the final Aggregate Principal Amount of the Notes to be issued on 30 April 2020 will be USD 6,220,000;

(b) the title of the Securities is now "Issue of USD 6,220,000 Citigroup Inc. USD 5y Callable Step Up (referred to by the Distributor as "Citigroup Step Up Callable USD Aprile 2025")";

(c) the final Distribution Fee payable to the Distributor in respect of the Notes to be issued on 30 April 2020 will be 2.50 per cent. of the Aggregate Principal Amount; and

(d) the final Structuring Fee payable to the Lead Manager in respect of the Notes to be issued on 30 April 2020 will be 0.625 per cent. of the Aggregate Principal Amount.

 

 

Capitalised terms used but not defined herein shall be as defined in the Final Terms.

 

This Notice and the Final Terms shall be read and construed together as one document.

 

 

 

 

Signed on behalf of

Citigroup Inc.

 

By: ...............................................

Duly authorised

 

This announcement has been issued through the Companies Announcement Service of Euronext Dublin.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ISEKKKBBDBKDBQN
Date   Source Headline
21st Apr 20214:25 pmRNSForm 8.3 - offeree
20th Apr 20213:43 pmRNSForm 8.3 - offeree
19th Apr 20214:58 pmRNSForm 8.3 - offeree
16th Apr 20214:40 pmRNSForm 8.3 - offeree
15th Apr 20213:22 pmRNSForm 8.3 - offeree
14th Apr 20213:38 pmRNSForm 8.3 - offeree
13th Apr 20211:37 pmRNSForm 8.3 - offeree
12th Apr 20213:45 pmRNSForm 8.3 - offeree
9th Apr 20213:19 pmRNSForm 8.3 - offeree
8th Apr 20213:46 pmRNSForm 8.3 - offeree
7th Apr 20213:58 pmRNSForm 8.3 - offeree
6th Apr 20213:33 pmRNSForm 8.3 - offeree
6th Apr 20219:40 amRNSForm 8.3 - offeree
1st Apr 20214:40 pmRNSForm 8.3 - offeree
31st Mar 20213:56 pmRNSForm 8.3 - offeree
30th Mar 20215:13 pmRNSForm 8.3 - [offeree]
29th Mar 20212:47 pmRNSForm 8.3 - [offeree]
29th Mar 20217:00 amRNSForm 8.3 - [offeror]
26th Mar 20215:19 pmRNSForm 8.3 - [Offeror]
30th Apr 202012:25 pmRNSArticle 8
27th Apr 202010:09 amRNSDelisting of Notes Series EMTN6619

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.